KESHA STEIGHNER: Open Payments
NPI 1285705913 · OLEAN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$955 in 56 payments from 11 companies in 2025. Trend: 2023 $1,086 · 2024 $586 · 2025 $955
Food & beverage: $862Education: $93
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 25 | $289 |
| Janssen Biotech, Inc. | 9 | $205 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $104 |
| Aimmune Therapeutics, Inc. | 4 | $92 |
| PFIZER INC. | 3 | $62 |
| Phathom Pharmaceuticals, Inc. | 4 | $57 |
| Lilly USA, LLC | 2 | $48 |
| Madrigal Pharmaceuticals | 2 | $45 |
| Novo Nordisk Inc | 1 | $26 |
| DePuy Synthes Sales Inc. | 1 | $18 |
Products named: TREMFYA, LINZESS, RINVOQ, ENTYVIO, SKYRIZI, VOWST, XELJANZ, VOQUEZNA.
Industry payments across NY — which companies pay providers there.
